Investment Analysts’ Recent Ratings Changes for Envista (NVST)

Several brokerages have updated their recommendations and price targets on shares of Envista (NYSE: NVST) in the last few weeks:

• 5/5/2025 – Envista had its price target lowered by analysts at UBS Group AG from $21.00 to $18.00. They now have a “neutral” rating on the stock.
• 5/2/2025 – Envista was given a new $21.00 price target on by analysts at Robert W. Baird.
• 4/30/2025 – Envista had its price target lowered by analysts at Piper Sandler from $18.00 to $17.00. They now have a “neutral” rating on the stock.
• 4/29/2025 – Envista had its price target lowered by analysts at Bank of America Co. from $26.00 to $23.00. They now have a “buy” rating on the stock.
• 4/15/2025 – Envista was given a new $16.00 price target on by analysts at Morgan Stanley.

Envista Stock Up 5.7%

NVST stock traded up $1.01 during trading hours on Monday, hitting $18.60. The company’s stock had a trading volume of 1,452,904 shares, compared to its average volume of 2,796,229. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $3.15 billion, a PE ratio of -2.87, a price-to-earnings-growth ratio of 1.27 and a beta of 0.97. Envista Holdings Co. has a 12 month low of $14.22 and a 12 month high of $23.00. The stock has a 50 day moving average price of $16.48 and a two-hundred day moving average price of $19.00.

Envista (NYSE:NVST) last posted its earnings results on Thursday, May 1st. The company reported $0.24 EPS for the quarter, topping the consensus estimate of $0.20 by $0.04. The company had revenue of $616.90 million during the quarter, compared to the consensus estimate of $608.17 million. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. The company’s revenue for the quarter was down 1.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.26 earnings per share. On average, equities research analysts expect that Envista Holdings Co. will post 1 earnings per share for the current year.

Institutional Trading of Envista

Large investors have recently modified their holdings of the company. Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Envista during the 4th quarter worth $53,000. Lecap Asset Management Ltd. bought a new stake in shares of Envista during the 4th quarter worth $281,000. Hantz Financial Services Inc. boosted its holdings in Envista by 146.6% in the 4th quarter. Hantz Financial Services Inc. now owns 110,489 shares of the company’s stock valued at $2,131,000 after purchasing an additional 65,679 shares during the period. Norges Bank bought a new stake in Envista in the 4th quarter valued at $38,052,000. Finally, Natixis Advisors LLC boosted its holdings in Envista by 1.8% in the 4th quarter. Natixis Advisors LLC now owns 106,652 shares of the company’s stock valued at $2,057,000 after purchasing an additional 1,845 shares during the period.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.